Strategic Advisory
for Life Sciences
Helping Biotech Innovators Navigate Capital Solutions, Partnerships, and Commercial Strategy
Axe Biostrategy is a life sciences advisory firm that supports a diverse range of biotech industry stakeholders with business development, commercial strategy, and non-dilutive financing solutions — particularly royalty financing.
Drawing on over a decade of consulting, investing, and corporate strategy experience, the firm delivers independent analysis and hands-on execution support to help clients evaluate opportunities and unlock the full value of their assets.
Our Focus
From early innovation to value realization, we understand how scientific, clinical, regulatory, and market dynamics shape outcomes across the life sciences ecosystem.
We operate where complexity is the norm — bringing rigorous analysis, focused strategic thinking, and disciplined transaction expertise to deliver clear insight and confident decision-making.
Bespoke Services
-
Advising royalty holders—biopharma companies, academic institutions, foundations, inventors, and investors—on royalty monetization strategies and alternative non-dilutive financing options
-
Due diligence and transaction exeuction support
Sourcing & origination strategy development
-
Licensing, partnerships, and M&A support
Asset valuation and deal structuring
-
Market landscaping and competitive intelligence
Forecasting & valuation
Indication prioritization and go-to-market planning
